W C Walker1,2,3, W Carne1,2, L M Franke1,2,3, T Nolen4, S D Dikmen5, D X Cifu1,2, K Wilson4, H G Belanger6,7,8, R Williams4. 1. a Department of Physical Medicine & Rehabilitation , Virginia Commonwealth University , Richmond , VA , USA. 2. b Hunter Holmes McGuire Veterans Affairs Medical Center , Richmond , VA , USA. 3. c Defense and Veterans Brain Injury Center , Richmond , VA , USA. 4. d RTI International , Research Triangle Park , NC , USA. 5. e Department of Rehabilitation Medicine , University of Washington , Seattle , WA , USA. 6. f HSR&D Center of Innovation on Disability and Rehabilitation Research (CINDRR) , Tampa , FL , USA. 7. g Department of Mental Health and Behavioral Sciences , James A. Haley Veterans' Hospital (VH) , Tampa , FL , USA. 8. h Department of Psychiatry and Behavioral Neurosciences , University of South Florida , Tampa , FL , USA.
Abstract
PRIMARY OBJECTIVES: To establish and comprehensively evaluate a large cohort of US veterans who served in recent military conflicts in order to better understand possible chronic and late-life effects of mild traumatic brain injury (mTBI), including those that may stem from neurodegeneration. RESEARCH DESIGN: Cross-sectional and prospective longitudinal. METHODS AND PROCEDURES: Inclusion criteria are prior combat exposure and deployment(s) in Operation Enduring Freedom, Operation Iraqi Freedom or one of their follow-on conflicts (collectively OEF/OIF). Effects of mTBI will be assessed by enrolling participants across the entire spectrum of mTBI, from entirely negative to many mTBIs. Longitudinal assessments consist of in-person comprehensive testing at least every 5 years, with interval annual telephonic testing. The primary outcome is the composite score on the NIH Toolbox neuropsychological test battery. Assessments also include structured interviews, questionnaires, traditional neuropsychological testing, motor, sensory and vestibular functions, neuroimaging, electrophysiology, genotypes and biomarkers. MAIN OUTCOMES AND RESULTS: The authors fully describe the study methods and measures and report demographic and exposure characteristics from the early portion of the cohort of OEF/OIF veterans. CONCLUSIONS: This centrepiece observational study of the Chronic Effects of Neurotrauma Consortium (CENC) is successfully launched and, within several years, should provide fertile data to begin investigating its aims.
PRIMARY OBJECTIVES: To establish and comprehensively evaluate a large cohort of US veterans who served in recent military conflicts in order to better understand possible chronic and late-life effects of mild traumatic brain injury (mTBI), including those that may stem from neurodegeneration. RESEARCH DESIGN: Cross-sectional and prospective longitudinal. METHODS AND PROCEDURES: Inclusion criteria are prior combat exposure and deployment(s) in Operation Enduring Freedom, Operation Iraqi Freedom or one of their follow-on conflicts (collectively OEF/OIF). Effects of mTBI will be assessed by enrolling participants across the entire spectrum of mTBI, from entirely negative to many mTBIs. Longitudinal assessments consist of in-person comprehensive testing at least every 5 years, with interval annual telephonic testing. The primary outcome is the composite score on the NIH Toolbox neuropsychological test battery. Assessments also include structured interviews, questionnaires, traditional neuropsychological testing, motor, sensory and vestibular functions, neuroimaging, electrophysiology, genotypes and biomarkers. MAIN OUTCOMES AND RESULTS: The authors fully describe the study methods and measures and report demographic and exposure characteristics from the early portion of the cohort of OEF/OIF veterans. CONCLUSIONS: This centrepiece observational study of the Chronic Effects of Neurotrauma Consortium (CENC) is successfully launched and, within several years, should provide fertile data to begin investigating its aims.
Authors: Erin D Bigler; Tracy J Abildskov; Barry Eggleston; Brian A Taylor; David F Tate; Jo Ann Petrie; Mary R Newsome; Randall S Scheibel; Harvey Levin; William C Walker; Naomi Goodrich-Hunsaker; Nicholas J Tustison; James R Stone; Andrew R Mayer; Timothy D Duncan; Gerry E York; Elisabeth A Wilde Journal: Int J Methods Psychiatr Res Date: 2019-05-23 Impact factor: 4.035
Authors: Peter C Fino; Lee E Dibble; Elisabeth A Wilde; Nora F Fino; Paula Johnson; Melissa M Cortez; Colby R Hansen; Susanne M van der Veen; Karen M Skop; J Kent Werner; David F Tate; Harvey S Levin; Mary Jo V Pugh; William C Walker Journal: Neurology Date: 2022-05-16 Impact factor: 11.800
Authors: Emily L Dennis; Brian A Taylor; Mary R Newsome; Maya Troyanskaya; Tracy J Abildskov; Aaron M Betts; Erin D Bigler; James Cole; Nicholas Davenport; Timothy Duncan; Jessica Gill; Vivian Guedes; Sidney R Hinds; Elizabeth S Hovenden; Kimbra Kenney; Mary Jo Pugh; Randall S Scheibel; Pashtun-Poh Shahim; Robert Shih; William C Walker; J Kent Werner; Gerald E York; David X Cifu; David F Tate; Elisabeth A Wilde Journal: Brain Inj Date: 2022-02-05 Impact factor: 2.167
Authors: William C Walker; Justin O'Rourke; Elisabeth Anne Wilde; Mary Jo Pugh; Kimbra Kenney; Clara Libby Dismuke-Greer; Zhining Ou; Angela P Presson; J Kent Werner; Jacob Kean; Deborah Barnes; Amol Karmarkar; Kristine Yaffe; David Cifu Journal: Brain Inj Date: 2022-02-02 Impact factor: 2.167